These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 25533683

  • 1. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K, Hoshino J, Ueno T, Hazue R, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, Ubara Y.
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [Abstract] [Full Text] [Related]

  • 2. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K, Hoshino J, Ueno T, Hazue R, Hasegawa J, Sekine A, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, Ubara Y.
    Clin J Am Soc Nephrol; 2016 Apr 07; 11(4):593-601. PubMed ID: 26801478
    [Abstract] [Full Text] [Related]

  • 3. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
    Yamanouchi M, Furuichi K, Hoshino J, Toyama T, Hara A, Shimizu M, Kinowaki K, Fujii T, Ohashi K, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Mise K, Makino H, Matsuo S, Ubara Y, Wada T, Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development.
    Diabetes Care; 2019 May 07; 42(5):891-902. PubMed ID: 30833372
    [Abstract] [Full Text] [Related]

  • 4. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T.
    Nephrology (Carlton); 2012 Jan 07; 17(1):68-75. PubMed ID: 21933307
    [Abstract] [Full Text] [Related]

  • 5. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M, Hoshino J, Ubara Y, Takaichi K, Kinowaki K, Fujii T, Ohashi K, Mise K, Toyama T, Hara A, Kitagawa K, Shimizu M, Furuichi K, Wada T.
    PLoS One; 2018 Jan 07; 13(1):e0190930. PubMed ID: 29338014
    [Abstract] [Full Text] [Related]

  • 6. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
    Kim JH, Kim SS, Kim IJ, Lee MJ, Jeon YK, Kim BH, Song SH, Kim YK.
    J Diabetes Complications; 2017 Feb 07; 31(2):395-399. PubMed ID: 27913013
    [Abstract] [Full Text] [Related]

  • 7. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S, Park J, Kim J, Jang HR, Kwon GY, Huh W, Kim YG, Kim DJ, Oh HY, Lee JE.
    J Diabetes Complications; 2017 Dec 07; 31(12):1704-1709. PubMed ID: 29037450
    [Abstract] [Full Text] [Related]

  • 8. Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy.
    Mise K, Hoshino J, Ueno T, Imafuku A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, Ubara Y.
    Diabet Med; 2015 Apr 07; 32(4):546-55. PubMed ID: 25400024
    [Abstract] [Full Text] [Related]

  • 9. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X, Ren L, Huang Y, Feng Z, Zhang G, Dai H.
    Clin Chim Acta; 2023 Jul 01; 547():117448. PubMed ID: 37331550
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.
    Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T.
    Nephrology (Carlton); 2013 Aug 01; 18(8):563-8. PubMed ID: 23714217
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy.
    Shimizu M, Furuichi K, Toyama T, Kitajima S, Hara A, Kitagawa K, Iwata Y, Sakai N, Takamura T, Yoshimura M, Yokoyama H, Kaneko S, Wada T, Kanazawa Study Group for Renal Diseases and Hypertension.
    Diabetes Care; 2013 Nov 01; 36(11):3655-62. PubMed ID: 24089538
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM, Wada T, Chiang CK.
    Clin Exp Nephrol; 2017 Apr 01; 21(2):307-315. PubMed ID: 27339442
    [Abstract] [Full Text] [Related]

  • 13. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China.
    Zhu X, Xiong X, Yuan S, Xiao L, Fu X, Yang Y, Tang C, He L, Liu F, Sun L.
    J Diabetes Complications; 2016 Apr 01; 30(3):537-41. PubMed ID: 26796433
    [Abstract] [Full Text] [Related]

  • 14. A pathological scoring system to predict renal outcome in diabetic nephropathy.
    Hoshino J, Mise K, Ueno T, Imafuku A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Hara S, Fujii T, Ohashi K, Ubara Y, Takaichi K.
    Am J Nephrol; 2015 Apr 01; 41(4-5):337-44. PubMed ID: 26067713
    [Abstract] [Full Text] [Related]

  • 15. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
    Li L, Zhang X, Li Z, Zhang R, Guo R, Yin Q, Yang L, Yue R, Su B, Huang S, Xu H, He C, Liu F.
    J Diabetes Complications; 2017 Jan 01; 31(1):114-121. PubMed ID: 27838100
    [Abstract] [Full Text] [Related]

  • 16. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS, Song SH, Kim IJ, Lee EY, Lee SM, Chung CH, Kwak IS, Lee EK, Kim YK.
    J Diabetes Complications; 2016 Jul 01; 30(5):887-92. PubMed ID: 27037042
    [Abstract] [Full Text] [Related]

  • 17. Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy.
    Shimizu M, Furuichi K, Kitajima S, Toyama T, Oshima M, Ogura H, Sato K, Nakagawa S, Yamamura Y, Miyagawa T, Hara A, Iwata Y, Sakai N, Kitagawa K, Yoshimura M, Yokoyama H, Wada T.
    BMC Nephrol; 2021 Sep 25; 22(1):319. PubMed ID: 34560842
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for progression of renal disease in patient with diabetic nephropathy.
    Unsal A, Koc Y, Basturk T, Akgun AO, Sakaci T, Ahbap E.
    Eur Rev Med Pharmacol Sci; 2012 Jul 25; 16(7):878-83. PubMed ID: 22953635
    [Abstract] [Full Text] [Related]

  • 19. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
    Misra PS, Szeto SG, Krizova A, Gilbert RE, Yuen DA.
    BMC Nephrol; 2020 Jul 18; 21(1):285. PubMed ID: 32682403
    [Abstract] [Full Text] [Related]

  • 20. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
    Provenzano M, Chiodini P, Minutolo R, Zoccali C, Bellizzi V, Conte G, Locatelli F, Tripepi G, Del Vecchio L, Mallamaci F, Di Micco L, Russo D, Heerspink HJL, De Nicola L.
    Nephrol Dial Transplant; 2020 Jan 01; 35(1):138-147. PubMed ID: 30053127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.